Share of Sales Subject to Medicare Inflation Rebates and Price Increases of Top‐Selling Drugs.
| Publicado en: | Health Services Research Vol. 61; no. 1; pp. 1 - 10 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
Jan2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194234639&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194234639 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00179124 HSR jtl: Health Services Research issn: 00179124 maglogo: Y pubinfo: dt: Jan2026 vid: 61 iid: 1 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 194234639 186584827 10.1111/1475-6773.70012 194234639 ppf: 1 ppct: 9 formats: tig: atl: Share of Sales Subject to Medicare Inflation Rebates and Price Increases of Top‐Selling Drugs. aug: au: Egilman, Alexander C. Kesselheim, Aaron S. Rome, Benjamin N. affil: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston Massachusetts,, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|